6 results

• Illegal Rapamune Marketing Leads to $491M Whistleblower Settlement

  July 31, 2013

  Irvin Jackson

  Pfizer pays $491M to settle charges that Wyeth illegally marketed the immunosuppressant Rapamune.

• DOJ to Intervene in Rapamune Whistleblower Lawsuit Against Pfizer

  September 22, 2010

  Staff Writers

  The federal government and a number of states have decided to intervene in a whistleblower lawsuit that accuses Pfizer’s Wyeth...

• Pfizer Faces Criminal Investigation Over Rapamune Marketing

  March 9, 2010

  Staff Writers

  Federal prosecutors have opened a criminal investigation into Wyeth’s promotions and marketing activities involving the organ transplant drug Rapamune.

• Kidney Transplant Drugs Receive New Warnings About Infection Side Effects

  July 15, 2009

  AboutLawsuits

  The FDA is requiring new warnings on several immunosuppressant drugs designed to prevent renal transplant patients from rejecting new kidneys....

• Rapamune Side Effects May Increase Risk of Death After Liver Transplant: FDA

  June 15, 2009

  AboutLawsuits

  The FDA has issued a warning to transplant doctors that switching their patients to the anti-organ transplant rejection drug Rapamune...

• Rapamune (sirolimus) Lawsuits

  May 30, 2008

  AboutLawsuits

  Recent research suggests that Rapamune, also known as sirolimus, may increase the risk of diabetes after a kidney transplant. This...